InvestorsHub Logo
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
SpecTrader Free
12/13/10 3:34 PM
profile icon
wickerman Free
12/13/10 3:05 PM
profile icon
wickerman Free
12/13/10 10:47 AM
profile icon
SpecTrader Free
12/11/10 2:14 AM
profile icon
wickerman Free
12/10/10 11:44 AM
profile icon
SpecTrader Free
12/10/10 12:27 AM
profile icon
SpecTrader Free
12/07/10 1:04 PM
profile icon
wickerman Free
12/07/10 9:28 AM
profile icon
wickerman Free
11/29/10 2:13 PM
profile icon
Stock Free
04/30/09 12:40 AM

Emergent Group, Inc. (LZR) RSS Feed

Posts (Today)
Posts (Total)
Moderators Daily Market Movers Digest Midday Report for Tuesday, August 12th MGRN, PYTO, EMGP, SPNG

Aug 12, 2008 (M2 PRESSWIRE via COMTEX) -- Our Stocks to Watch today include Monogram Energy Inc. (OTC: MGRN), PhytoMedical Technologies Inc. (OTCBB: PYTO), Emergent Group Inc. (OTCBB: EMGP), SpongeTech Delivery Systems Inc. (OTCBB: SPNG)
Visit to register for our Daily Market Mover's Digest Newsletter and Email Stock Watch Alerts.


Detailed Quote:

Company Profile:

Monogram Energy, Inc. is an independent energy company engaged in the acquisition, development, and exploitation of oil and gas properties. The company specializes in acquiring oil & gas leases with proven reserves that have the potential for increased production.

MGRN News:

August 11 - Monogram Energy Inc. to Workover Three Wells

Monogram Energy Inc. (OTC: MGRN) announced that the workover of three wells on the T.W. Martin lease is scheduled to begin today. Upon completion, the Company expects to see a substantial increase in the production of these wells.

Mr. Billy King, Chief Executive Officer of Monogram Energy, Inc., stated, "We're anxious to get this completed, as we are anticipating some very positive results."

Mr. King became interested in the production of oil & gas during his ten years of employment as an attorney for the Halliburton Company, and with his representation of independent oil companies during his years as a private practitioner. Monogram Energy's goal is to maintain a high risk/reward profile, thereby enabling them to return the most value to its shareholders.


Detailed Quote:

PhytoMedical Technologies, Inc. (OTCBB: PYTO) (Frankfurt Stock Exchange: ET6), together with its wholly owned subsidiaries, is a pharmaceutical company focused on research, development and commercialization of pharmaceutical products. For additional information, visit

PYTO News:

August 11 - PhytoMedical Acquires Worldwide License Rights to Patented Novel Anti-Cancer Compounds from Dartmouth College

Patented anti-cancer compounds kill difficult-to-treat human cancer cells, including glioblastoma (brain cancer), colon cancer, and small cell lung cancer, in ongoing in vitro tests

PhytoMedical Technologies, Inc. (OTCBB: PYTO) (FWB: ET6), announced that it has entered into an exclusive worldwide license agreement with Dartmouth College to develop, market and distribute new anti-tumor bis-acridines, bis-ellipticines and bis-carbazoles known as intercalating agents developed by leading researcher, Dr. Gordon Gribble, of Dartmouth College.

Under terms of the agreement, PhytoMedical agreed to pay an undisclosed license fee and milestone payments to Dartmouth. The Company plans to develop these innovative anti-cancer compounds as a new class of compounds for cancer treatment, unique among existing pharmacological treatments. A series of ongoing tests on human cancer cells have demonstrated the anti-tumor capability of these compounds, prompting the Company to undertake further testing and development.

"We are very pleased to enter into this agreement with Dartmouth College," stated Mr. Greg Wujek, President and CEO of PhytoMedical Technologies, Inc. "Dr. Gordon Gribble, who developed these intercalating agents and leads the research project, has been a chemistry professor at Dartmouth for over three decades and currently holds an endowed Chair as "The Dartmouth Professor of Chemistry." The development Dr. Gribble's compounds holds promise as a potentially entirely new class of compounds to help fight cancer."

These anti-cancer compounds are designed to bind more tightly to cancer cell DNA than many conventional anticancer drugs by a process called bis-intercalation or "double binding," much like a molecular staple. Because the DNA is the blueprint of life for the cancer cell, such binding stops the replication of the DNA, which prevents the growth of the cancer cell and it dies.

EMERGENT GROUP INCORPORATED (OTCBB: EMGP) "Up 25.53% in morning trading"

Detailed Quote:

Emergent Group Inc., through its wholly owned subsidiary, PRI Medical Technologies Inc. ("PRI Medical"), provides mobile laser and surgical equipment on a per procedure basis to hospitals, out-patient surgery centers, and physicians' offices. Surgical equipment is provided to customers along with technical support personnel to ensure that such equipment is operating correctly. PRI Medical currently offers its services in five states in the western United States and eleven states along the eastern seaboard. For product and other information, visit PRI Medical's website at

EMGP News:

August 12 - Emergent Group Inc. Reports Record EPS of $0.12 on Record Sales for Second Quarter

Profit Nearly Double 2007 Level

Emergent Group Inc. (OTCBB: EMGP), a leading provider of mobile medical lasers and surgical equipment, announced results for the second quarter ended June 30, 2008. Revenues for the quarter increased 13% to a record $4,901,549 compared to revenues of $4,331,488 for the same period in 2007. Net income increased 97% to $711,368 or $0.12 per basic share for the second quarter as compared to net income of $361,204 or $0.07 per basic share for the same period in 2007.

"Our strong financial performance in the second quarter of 2008 represents our eleventh consecutive quarter of year over year sales growth,'' said Bruce J. Haber, Emergent Group Chairman and CEO. "Particularly satisfying is the nearly doubling of our quarterly profit on the eve of expanding our business model into eleven new states following the recently announced purchase of the assets of PhotoMedex Surgical Services ('PSS'), a division of PhotoMedex, Inc.,'' added Mr. Haber.

"On August 8, 2008, we closed the PSS asset purchase. The PSS division recorded sales of $7,667,000 for the year ended December 31, 2007, equal to 43% of Emergent's sales of $17,662,000 for the same period,'' added Mr. Haber. "We expect the division to be accretive to Emergent Group's earnings for 2008 and represent a large future growth opportunity.''

He further remarked, "Our confidence in our business and prospects is reinforced by our continued strong cash generation and demonstrated by the payment of a $0.30 per share cash dividend in January, 2008, an increase of 50% over the prior year.''


Detailed Quote:

Spongetech Delivery Systems, Inc. engages in the design, production, marketing, and distribution of hydrophilic polyurethane sponge cleaning and waxing products primarily for vehicular use in the United States. The company utilizes patented technology relating to sponges containing hydrophilic, which are liquid absorbing, foam polyurethane matrices. Its product portfolio comprises specially configured sponges containing an outer contact layer and an inner matrix; children's bath foam sponge with a safe mesh coating, which prevents tearing; and household cleaning sponges infused with anti-bacterial bath and kitchen soaps. The company was founded in 1999 and is based in New York, New York.

SPNG News:

August 12 - SpongeTech Delivery Systems, Inc., President and CEO, Michael L. Metter; Clarification Statement to Our Shareholders and All Interested Parties

SpongeTech's President and CEO Releases Statement

SpongeTech Delivery Systems, Inc. (OTCBB: SPNG) President and CEO of SpongeTech , Michael L. Metter, states, "The last audited financials for our 2007 fiscal year, which ended May 30, 2007, shows very clearly that we did under $100,000 in revenue. The 2008 year that has just ended May 31, 2008, which we will be reporting on shortly, will show in excess of $5.3 million and will be very profitable. Respectfully, what bank, or investment-banking source, would lend us significant capital to grow our business with such a short track record without major dilution, especially with the horrible credit crunch that the American economy has suffered over the last eight months?

The officers, directors, and key investors of SpongeTech have lent the business, interest free, approximately $5 million. SpongeTech , as our numbers will confirm, will grow rapidly during the 2009 fiscal year, and we are right on target to meet or even exceed projections in excess of $30 million. We are growing SpongeTech for all our shareholders and, as we have stated in a recent 8K Filing, we expect to buy back the stock that has been issued for financing and advertising purposes within 18 months. These shares are definitely restricted and cannot be sold. I hope this answers some of the questions that have been directed to the company. I want to thank all shareholders for their continued support." Sincerely, Michael L. Metter, President and CEO SpongeTech Delivery Systems, Inc.

For more information, contact Investor Relations at 1-877-SPONGE-T, and/or visit the Company's website at

ABOUT OTCPICKS.COM is an Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Profile Research Reports authored by our financial writers. We publish a daily Newsletter to subscribers, and we publish our Daily Market Movers Digest which is sent out on the M2 Presswire several times daily highlighting hot OTC and OTCBB stocks. To feature a company on our web site or in our daily Newsletter or Market Mover's Digest, please contact our publisher, Brian Dean at 972-546-3740, or via email at

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. This disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE: The employees are NOT Registered as an Investment Advisor in any jurisdiction whatsoever.

Release of Liability: Through use of this website viewing or using you agree to hold, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a representation by the publisher nor a solicitation of the purchase or sale of any securities. has received fifty thousand free trading shares from a non-controlling third party (Microcap Management) for MGRN advertising and promotional services. has been compensated seventeen thousand dollars by the company and four hundred thousand free trading shares by a non-controlling third party for multiple 30-day SPNG IR programs. For a complete list of disclosures go to The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. and its affiliates are not registered investment advisors or a broker dealers. has been advised that the investments in companies profiled are considered to be high risk and use of the information provided is at the investor's sole risk. also advises that the purchase of such high risk securities may result in the loss of some or all of the investment. Investors should not rely solely on the information presented. Rather, investors should use the information provided by the profiled companies as a starting point for doing additional independent research on the profiled companies in order to allow the investor to form his or her own opinion regarding investing in the profiled companies. Factual statements made by the profiled companies are made as of the date stated and are subject to change without notice. Investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through owners may or may not hold positions in the companies that are profiled.

The information contained herein contains forward-looking information within the meaning of Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 including statements regarding expected continual growth of the company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect the company's actual results of operation. Factors that could cause actual results to differ include the size and growth of the market for the company's products, the company's ability to fund its capital requirements in the near term and in the long term, pricing pressures, unforeseen and/or unexpected circumstances in happenings, pricing pressures, etc. Investing in securities is speculative and carries risk. Past performance does not guarantee future results.

Third Party Web Sites and Information: and newsletter may provide hyperlinks to third party websites or access to third party content. does not control, endorse, or guarantee content found in such sites. You agree that is not responsible for any content, associated links, resources, or services associated with a third party site. You further agree that shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only.

CONTACT: Brian Dean, Publisher, Tel: +1 972 546 3740 e-mail:

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at on the world wide web. Inquiries to


Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
LZR Latest News
  • No Recent News Available for this company!
New Post